decisionhealth Newsletters, Part B News - 2003 Issue 3 (March)
90782 should not be bundled into drug code payments, CMS says
Subscribe or sign in to view the full article.
Article Overview
This article examines a Medicare billing/payment issue involving CMS guidance, carrier practices, and claim denials related to injection administration services reported alongside drug claims and other physician fee schedule services. It is relevant to coders, billing staff, compliance personnel, and physician practices that need to understand the scope of CMS guidance, carrier interpretation, and common office scenarios involving patient-supplied medication.
Why This Topic Matters
The piece helps readers understand a reported discrepancy between carrier behavior and CMS guidance, along with the broader payment context for administration services in Medicare billing. It is especially important for practices that bill drug-related encounters and need to assess when administration services may or may not be separately payable.
What You Will Learn
- How the article frames CMS and carrier-level billing concerns for injection administration services
- What general payment context Medicare applies when an injection administration service is reported with other covered services
- How the article describes situations involving patient-supplied medication in the office setting
- Which organizations and provider stakeholders are involved in the reported payment dispute
Who Should Read This
- Medical coders
- Billing staff
- Compliance officers
- Physician practices
- Practice managers
- Medicare billing professionals
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com